Targeting the Endoplasmic Reticulum Oxidoreductin-1 Alpha-Protein Disulfide Isomerase Redox Interface as a Therapeutic Strategy in Cancer.
Saved in:
| Title: | Targeting the Endoplasmic Reticulum Oxidoreductin-1 Alpha-Protein Disulfide Isomerase Redox Interface as a Therapeutic Strategy in Cancer. |
|---|---|
| Authors: | Khojayeva K; Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan., Zhussipbekkyzy A; Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan., Balkybayeva D; Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan., Sabit K; Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan., Lopes LR; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-900, Brazil., Sagatbekova K; Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan., Zhakupova A; Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan., Aljofan M; Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan. |
| Source: | Biomedicines [Biomedicines] 2026 Jan 23; Vol. 14 (2). Date of Electronic Publication: 2026 Jan 23. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
